Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody–drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study
Anas Gazzah, Philippe Lucien Bedard, Cinta Hierro, Yubin Kang, Albiruni Abdul Razak, M.-H. Ryu and 6 more
- Rank
- 58 of 3,616
- Percentile
- top 1.7%
- Where
- Annals of Oncology, 2022
- Citations
- 83
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.